Literature DB >> 19842236

Controversies about occult hepatitis B virus infection.

Ersan Ozaslan, Tugrul Purnak.   

Abstract

We read with great interest the paper written by Shi et al, reviewing the molecular characteristics and stages of chronic hepatitis B virus (HBV) infection. We think that some points in the definition of occult HBV infection (OBI) and their conclusion about the management of OBI may need further considerations.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19842236      PMCID： PMC2764983          DOI： 10.3748/wjg.15.4986

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


  14 in total

1.  Fatal HBV reactivation in a subject with anti-HBs and anti-HBc.

Authors:  Takeji Umemura; Kendo Kiyosawa
Journal:  Intern Med       Date:  2006-07-18       Impact factor: 1.271

2.  The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting.

Authors:  Stephen Barclay; Stanislas Pol; David Mutimer; Yves Benhamou; Peter R Mills; Peter C Hayes; Sheila Cameron; William Carman; William Cameron
Journal:  J Clin Virol       Date:  2008-01-18       Impact factor: 3.168

3.  Fatal reactivation of hepatitis B post-chemotherapy for lymphoma in a hepatitis B surface antigen-negative, hepatitis B core antibody-positive patient: potential implications for future prophylaxis recommendations.

Authors:  Joanna K Law; Jin K Ho; Paul J Hoskins; Siegfried R Erb; Urs P Steinbrecher; Eric M Yoshida
Journal:  Leuk Lymphoma       Date:  2005-07

4.  Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy.

Authors:  Chee-Kin Hui; Winnie W W Cheung; Hai-Ying Zhang; Wing-Yan Au; Yui-Hung Yueng; Anskar Y H Leung; Nancy Leung; John M Luk; Albert K W Lie; Yok-Lam Kwong; Raymond Liang; George K K Lau
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

5.  HBV reactivation with fatal fulminating hepatitis during rituximab treatment in a subject negative for HBsAg and positive for HBsAb and HBcAb.

Authors:  Cesare Sarrecchia; Alessandra Cappelli; Pasquale Aiello
Journal:  J Infect Chemother       Date:  2005-08       Impact factor: 2.211

Review 6.  Prophylaxis and treatment of hepatitis B in immunocompromised patients.

Authors:  A Marzano; E Angelucci; P Andreone; M Brunetto; R Bruno; P Burra; P Caraceni; B Daniele; V Di Marco; F Fabrizi; S Fagiuoli; P Grossi; P Lampertico; R Meliconi; A Mangia; M Puoti; G Raimondo; A Smedile
Journal:  Dig Liver Dis       Date:  2007-03-26       Impact factor: 4.088

7.  Pathological and virological findings in patients with persistent hypertransaminasaemia of unknown aetiology.

Authors:  C Berasain; M Betés; A Panizo; J Ruiz; J I Herrero; M P Civeira; J Prieto
Journal:  Gut       Date:  2000-09       Impact factor: 23.059

8.  Long-term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donor.

Authors:  A Knöll; S Boehm; J Hahn; E Holler; W Jilg
Journal:  J Viral Hepat       Date:  2007-07       Impact factor: 3.728

Review 9.  Clinical impact of occult HBV infections.

Authors:  I Chemin; C Trépo
Journal:  J Clin Virol       Date:  2005-12       Impact factor: 3.168

Review 10.  Occult hepatitis B.

Authors:  Michael Torbenson; David L Thomas
Journal:  Lancet Infect Dis       Date:  2002-08       Impact factor: 25.071
View more
  5 in total

1.  Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt.

Authors:  Abeer Elkady; Sahar Aboulfotuh; Elsayed Mostafa Ali; Douaa Sayed; Nashwa M Abdel-Aziz; Amany M Ali; Shuko Murakami; Sayuki Iijima; Yasuhito Tanaka
Journal:  World J Gastroenterol       Date:  2013-10-07       Impact factor: 5.742

Review 2.  An overview of occult hepatitis B virus infection.

Authors:  Zeinab Nabil Ahmed Said
Journal:  World J Gastroenterol       Date:  2011-04-21       Impact factor: 5.742

3.  Prevalence of occult hepatitis B amongst Indian human immunodeficiency virus type 1 infected individuals-a pilot study.

Authors:  Sourav Sen; Shakti Prasad Panda; K Shanmuganandan; Rm Gupta; Ak Praharaj
Journal:  Med J Armed Forces India       Date:  2012-01-18

4.  The prevalence of occult hepatitis B virus (HBV) infection in a large multi-ethnic haemodialysis cohort.

Authors:  Luciana Sowole; Wendy Labbett; Mauli Patel; Aisling O'Riordan; Jennifer Cross; Andrew Davenport; Tanzina Haque
Journal:  BMC Nephrol       Date:  2015-02-06       Impact factor: 2.388

5.  First report of occult hepatitis B infection among ART naïve HIV seropositive individuals in Maputo, Mozambique.

Authors:  Awa Abdul Carimo; Eduardo Samo Gudo; Cremildo Maueia; Nédio Mabunda; Lúcia Chambal; Adolfo Vubil; Ana Flora; Francisco Antunes; Nilesh Bhatt
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.